查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954667

全球安全注射筆針市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034）

Safety Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 請詢問到貨日

價格

安全注射筆針市場成長驅動因素

2025年全球安全注射筆針市場規模為7.6802億美元，預計將從2026年的8.1852億美元增長至2034年的14.9331億美元，預測期內複合年增長率（CAGR）為7.81%。 北美將在2025年以42.34%的市場佔有率引領市場，這得益於其糖尿病高發生率、先進的醫療基礎設施以及主要製造商的強大實力。

安全筆針是用於胰島素筆的無菌一次性針頭，具有針頭保護罩和自動回縮系統等保護功能，可防止針刺傷。 這些裝置提高了患者和照護者的安全，並且越來越受到人們的青睞，優於傳統的注射器和標準筆針。

市場動態

市場驅動因素

糖尿病盛行率上升

全球糖尿病負擔日益加重是主要的成長驅動因素。根據國際糖尿病聯盟（IDF）發布的 "糖尿病地圖集" （2025年版），20-79歲成年人口中約有11.1%患有糖尿病。快速的都市化、久坐的生活方式和不斷上升的肥胖率是導致胰島素依賴性增加的重要因素。 由於胰島素治療需要頻繁注射，因此對更安全、更方便的注射裝置（例如安全筆針）的需求持續成長。

此外，已開發國家推廣安全注射實踐的宣傳活動日益增多，也促進了產品普及率的提高。

市場限制因子

替代給藥系統的興起

無針替代給藥技術的發展可能會限制市場成長。 2024年11月，Sol-Millennium公司在美國推出了無針頭胰島素輸注裝置Insujet。此類技術進步為患者提供了創傷較小的選擇，並可以減少他們對安全筆針的依賴。

市場機會

轉向家庭醫療保健

對家庭糖尿病管理的需求不斷增長，帶來了巨大的市場成長機會。根據美國國家生物技術資訊中心（NCBI）2023年9月發布的報告，全球約有60%的胰島素使用者使用胰島素筆。 具有被動屏蔽和自動停用機制等功能的安全注射筆針頭適用於老年患者及其照護人員，因為它們可以降低受傷和交叉感染的風險。遠距病患監護和個人化醫療模式的擴展進一步推動了市場需求，尤其是在亞太和拉丁美洲等新興市場。

市場挑戰

安全注射筆針頭成本高

安全注射筆針頭比標準注射筆針頭貴得多。 2025年6月，英國國家醫療服務體系 (NHS) 指出，安全注射筆針頭的成本可能比傳統針頭高出八倍，這在註重成本的醫療保健系統中構成了處方限制因素。印度和中國等發展中國家缺乏報銷政策可能會進一步限制其普及。

市場趨勢

超細針技術的整合

製造商正在將超細針設計（最小4毫米，32-34號）與先進的安全機制結合。這些創新可減輕注射時的疼痛和焦慮，並提高胰島素依賴型患者的治療順從性。與製藥公司在GLP-1受體激動劑和胰島素筆方面的合作開發正在推動技術的進一步進步。

細分市場分析

依產品類型

2024年，主動安全胰島素筆針細分市場因其易用性和可靠的劑量輸送而成為市場主導。研究表明，醫療保健專業人員對此類產品非常滿意。被動安全胰島素筆針由於其自動屏蔽功能，無需手動操作，也佔了較大的市場佔有率。

依藥物類型

2024年，胰島素細分市場成為市場主導。這主要歸因於糖尿病盛行率的上升和新產品的頻繁上市。例如，2025年1月，諾和諾德在日本推出了 "Awicli（胰島素Icodec）" 。 GLP-1類藥物佔第二大市場佔有率，其成長主要得益於第2型糖尿病和肥胖症處方量的增加。

依疾病分類

2024年，糖尿病領域成為市場成長的主要驅動力，這得益於安全注射筆針頭的持續創新和家庭胰島素治療的普及。肥胖症領域佔第二大市場佔有率，主要歸因於其與第2型糖尿病的密切關聯。

依針頭尺寸分類

2024年，4毫米針頭成為主流。這是因為其副作用較少，並能降低肌肉注射的風險。臨床數據證實，即使在肥胖患者中，4毫米針頭也安全可靠。

依分銷管道分類

2024年，零售藥局通路佔主導地位。全球連鎖藥局的擴張為此提供了支持。例如，CVS藥局於2025年3月宣布計畫在美國開設新店。由於其便利性和送貨上門的優勢，預計線上藥局將實現最高的複合年增長率。

區域洞察

2025年，北美維持領先地位，市場規模達3.2522億美元。監管審批、產品上市以及糖尿病的高發生率推動了其成長。

2024年，歐洲佔第二大市場佔有率，主要得益於糖尿病處方量的增加。根據英國國家醫療服務體系（NHS）的報告，2024年英國的糖尿病相關處方量為7,100萬張。

預計到2034年，亞太地區將實現最高的複合年增長率，這主要得益於糖尿病的高發病率和不斷擴大的分銷合作夥伴關係。 拉丁美洲和中東及非洲地區預計將保持穩定成長，這得益於肥胖率上升和醫療保健服務改善。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家和地區糖尿病盛行率（2025 年）
  • 主要國家和地區肥胖盛行率（2021-2034 年）
  • 主要產業趨勢：併購、業務合作等

第五章 全球安全注射筆針市場

分析：洞察與預測 (2021-2034)
  • 市場分析、洞察與預測：依產品類型劃分
    • 主動安全注射筆針
    • 被動安全注射筆針
  • 市場分析、洞察與預測：依藥物類型劃分
    • 胰島素
    • GLP-1
    • 生長激素
    • 其他
  • 市場分析、洞察與預測：依疾病劃分
    • 糖尿病
    • 肥胖症
    • 荷爾蒙缺乏症
    • 其他
  • 市場分析、洞察與預測：依藥物類型劃分
    • 4 毫米
    • 5 毫米
    • 6 毫米
    • 8 毫米
    • 12 毫米
  • 市場分析、洞察與預測：依分銷管道
    • 醫院藥房
    • 零售藥房
    • 線上藥房
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美安全注射筆針頭市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲安全注射筆針頭市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲國家

第八章：亞太地區安全注射筆針頭市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 其他亞太地區

第九章：拉丁美洲安全注射筆針頭市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章中東與非洲安全注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 其他中東和非洲國家/地區

第11章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
  • Embecta Corp.
  • Cardinal Health
  • MTD Medical Technology and Devices
  • UltiMed, Inc.
  • Allison Medical, Inc.
  • Owen Mumford
  • Medline Industries, LP.
  • VMG
  • Neon Diagnostics Limited
Product Code: FBI113841

Growth Factors of safety pen needles Market

The global safety pen needles market was valued at USD 768.02 million in 2025 and is projected to grow from USD 818.52 million in 2026 to USD 1,493.31 million by 2034, registering a CAGR of 7.81% during the forecast period. North America dominated the market with a 42.34% share in 2025, driven by high diabetes prevalence, advanced healthcare infrastructure, and strong presence of leading manufacturers.

Safety pen needles are sterile, single-use needles used with insulin pens, equipped with protective features such as needle shields or auto-retraction systems to prevent accidental needlestick injuries. These devices enhance safety for both patients and caregivers and are increasingly preferred over conventional syringes and standard pen needles.

Market Dynamics

Market Drivers

Rising Prevalence of Diabetes

The growing global burden of diabetes is a primary growth driver. According to the IDF Diabetes Atlas (2025), approximately 11.1% of the adult population aged 20-79 years is living with diabetes. Rapid urbanization, sedentary lifestyles, and rising obesity rates are significantly contributing to increased insulin dependency. As insulin therapy requires frequent injections, the demand for safer and more convenient injection devices such as safety pen needles is rising steadily.

Furthermore, increased awareness programs in developed nations promoting safe injection practices are supporting higher product adoption.

Market Restraints

Emergence of Alternative Drug Delivery Systems

The development of needle-free and alternative drug delivery technologies may limit market growth. In November 2024, Sol-Millennium launched the Insujet needle-free insulin delivery device in the U.S. Such advancements provide patients with less invasive options, potentially reducing reliance on safety pen needles.

Market Opportunities

Shift Toward Home Healthcare

The increasing preference for home-based diabetes management presents significant growth opportunities. Around 60% of global insulin users utilize insulin pens, as reported by NCBI (September 2023). Safety pen needles, with features such as passive shielding and auto-disable mechanisms, reduce injury risk and cross-contamination, making them suitable for elderly patients and caregivers. Expanding remote patient monitoring and personalized healthcare models are further strengthening demand, particularly in emerging markets across Asia Pacific and Latin America.

Market Challenges

High Cost of Safety Pen Needles

Safety pen needles are significantly more expensive than standard pen needles. In June 2025, the NHS highlighted that safety needles can be up to eight times more expensive than conventional needles, limiting prescriptions in cost-sensitive healthcare systems. Lack of reimbursement policies in developing nations such as India and China may further restrict adoption.

Market Trends

Integration of Ultra-Thin Needle Technology

Manufacturers are integrating ultra-thin needle designs (as small as 4 mm and 32-34 gauge) with advanced safety mechanisms. These innovations reduce injection pain and anxiety, enhancing therapy adherence among insulin-dependent patients. Co-development with pharmaceutical companies for GLP-1 agonists and insulin pens is further driving technological advancements.

Segmentation Analysis

By Product Type

The active safety pen needles segment dominated in 2024, driven by ease of use and reliable dose delivery. Studies have demonstrated high satisfaction levels among healthcare professionals. Passive safety pen needles also hold a substantial share due to automatic shielding features that eliminate manual activation.

By Drug Type

The insulin segment dominated in 2024, supported by rising diabetes prevalence and frequent product launches. For example, in January 2025, Novo Nordisk launched Awiqli (insulin icodec) in Japan. The GLP-1 segment held the second-largest share, fueled by increasing prescriptions for type 2 diabetes and obesity management.

By Disease Indication

The diabetes segment dominated in 2024, owing to continuous innovation in safety pen needles and increasing home-based insulin therapy. The obesity segment accounted for the second-largest share due to its link with type 2 diabetes.

By Needle Size

The 4 mm segment dominated in 2024, attributed to fewer side effects and reduced risk of intramuscular injections. Clinical data supports its safety even among obese individuals.

By Distribution Channel

The retail pharmacy segment dominated in 2024, supported by global expansion of pharmacy chains. For instance, in March 2025, CVS Pharmacy announced plans to open new stores across the U.S. Online pharmacies are expected to register the highest CAGR due to convenience and home delivery benefits.

Regional Insights

In 2025, North America generated USD 325.22 million, maintaining its leading position. Growth is supported by regulatory approvals, product launches, and high diabetes incidence.

Europe held the second-largest share in 2024, driven by rising diabetes prescriptions. The NHS reported 71 million diabetes-related prescriptions in 2024 in the U.K.

Asia Pacific is projected to register the highest CAGR through 2034, owing to high diabetes prevalence and increasing distribution partnerships. Latin America and the Middle East & Africa are expected to witness steady growth supported by rising obesity rates and improved healthcare access.

Competitive Landscape

Key players include Embecta Corp., Cardinal Health, MTD Medical Technology and Devices, UltiMed, Inc., Allison Medical, Owen Mumford, VMG, and Neon Diagnostics Limited. Companies are focusing on acquisitions, partnerships, and capacity expansions. Notably, in November 2024, Cardinal Health announced its acquisition of Advanced Diabetes Supply Group for USD 1.1 billion.

Conclusion

The global safety pen needles market is set for robust growth from USD 768.02 million in 2025 to USD 818.52 million in 2026, reaching USD 1,493.31 million by 2034 at a CAGR of 7.81%. Rising diabetes prevalence, increasing preference for home healthcare, and technological innovations in ultra-thin safety needles are key growth drivers. Although high product costs and emerging needle-free alternatives pose challenges, expanding healthcare awareness and strategic initiatives by major industry players are expected to sustain long-term market expansion through 2034.

Segmentation By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Region

By Product Type * Active Safety Pen Needles

  • Passive Safety Pen Needles

By Drug Type * Insulin

  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication * Diabetes

  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size * 4 mm

  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel * Hospital Pharmacy

  • Retail Pharmacy
  • Online Pharmacy

By Region * North America (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)

    • U.S.
    • Canada
  • Europe (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2025
  • 4.2. Prevalence of Obesity - by Key Countries/Regions, 2021-2034
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnership; etc.)

5. Global Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Active Safety Pen Needles
    • 5.1.2. Passive Safety Pen Needles
  • 5.2. Market Analysis, Insights and Forecast - By Drug Type
    • 5.2.1. Insulin
    • 5.2.2. GLP-1
    • 5.2.3. Growth Hormone
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.3.1. Diabetes
    • 5.3.2. Obesity
    • 5.3.3. Hormone Deficiency
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Drug Type
    • 5.4.1. 4 mm
    • 5.4.2. 5 mm
    • 5.4.3. 6 mm
    • 5.4.4. 8 mm
    • 5.4.5. 12 mm
  • 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.5.1. Hospital Pharmacy
    • 5.5.2. Retail Pharmacy
    • 5.5.3. Online Pharmacy
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Active Safety Pen Needles
    • 6.1.2. Passive Safety Pen Needles
  • 6.2. Market Analysis, Insights and Forecast - By Drug Type
    • 6.2.1. Insulin
    • 6.2.2. GLP-1
    • 6.2.3. Growth Hormone
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.3.1. Diabetes
    • 6.3.2. Obesity
    • 6.3.3. Hormone Deficiency
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Drug Type
    • 6.4.1. 4 mm
    • 6.4.2. 5 mm
    • 6.4.3. 6 mm
    • 6.4.4. 8 mm
    • 6.4.5. 12 mm
  • 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.5.1. Hospital Pharmacy
    • 6.5.2. Retail Pharmacy
    • 6.5.3. Online Pharmacy
  • 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Active Safety Pen Needles
    • 7.1.2. Passive Safety Pen Needles
  • 7.2. Market Analysis, Insights and Forecast - By Drug Type
    • 7.2.1. Insulin
    • 7.2.2. GLP-1
    • 7.2.3. Growth Hormone
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.3.1. Diabetes
    • 7.3.2. Obesity
    • 7.3.3. Hormone Deficiency
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Drug Type
    • 7.4.1. 4 mm
    • 7.4.2. 5 mm
    • 7.4.3. 6 mm
    • 7.4.4. 8 mm
    • 7.4.5. 12 mm
  • 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.5.1. Hospital Pharmacy
    • 7.5.2. Retail Pharmacy
    • 7.5.3. Online Pharmacy
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia pacific Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Active Safety Pen Needles
    • 8.1.2. Passive Safety Pen Needles
  • 8.2. Market Analysis, Insights and Forecast - By Drug Type
    • 8.2.1. Insulin
    • 8.2.2. GLP-1
    • 8.2.3. Growth Hormone
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.3.1. Diabetes
    • 8.3.2. Obesity
    • 8.3.3. Hormone Deficiency
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Drug Type
    • 8.4.1. 4 mm
    • 8.4.2. 5 mm
    • 8.4.3. 6 mm
    • 8.4.4. 8 mm
    • 8.4.5. 12 mm
  • 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.5.1. Hospital Pharmacy
    • 8.5.2. Retail Pharmacy
    • 8.5.3. Online Pharmacy
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Active Safety Pen Needles
    • 9.1.2. Passive Safety Pen Needles
  • 9.2. Market Analysis, Insights and Forecast - By Drug Type
    • 9.2.1. Insulin
    • 9.2.2. GLP-1
    • 9.2.3. Growth Hormone
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.3.1. Diabetes
    • 9.3.2. Obesity
    • 9.3.3. Hormone Deficiency
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Drug Type
    • 9.4.1. 4 mm
    • 9.4.2. 5 mm
    • 9.4.3. 6 mm
    • 9.4.4. 8 mm
    • 9.4.5. 12 mm
  • 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.5.1. Hospital Pharmacy
    • 9.5.2. Retail Pharmacy
    • 9.5.3. Online Pharmacy
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Active Safety Pen Needles
    • 10.1.2. Passive Safety Pen Needles
  • 10.2. Market Analysis, Insights and Forecast - By Drug Type
    • 10.2.1. Insulin
    • 10.2.2. GLP-1
    • 10.2.3. Growth Hormone
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.3.1. Diabetes
    • 10.3.2. Obesity
    • 10.3.3. Hormone Deficiency
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Drug Type
    • 10.4.1. 4 mm
    • 10.4.2. 5 mm
    • 10.4.3. 6 mm
    • 10.4.4. 8 mm
    • 10.4.5. 12 mm
  • 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.5.1. Hospital Pharmacy
    • 10.5.2. Retail Pharmacy
    • 10.5.3. Online Pharmacy
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. Embecta Corp.
    • 11.2.2. Cardinal Health
    • 11.2.3. MTD Medical Technology and Devices
    • 11.2.4. UltiMed, Inc
    • 11.2.5. Allison Medical, Inc.
    • 11.2.6. Owen Mumford
    • 11.2.7. Medline Industries, LP.
    • 11.2.8. VMG
    • 11.2.9. Neon Diagnostics Limited

List of Tables

  • Table 1: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 3: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 4: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size, 2021-2034
  • Table 5: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 6: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 7: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 8: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 9: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 10: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size, 2021-2034
  • Table 11: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 12: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Country, 2021-2034
  • Table 13: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 15: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 16: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size 2021-2034
  • Table 17: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 18: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034
  • Table 19: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 20: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 21: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 22: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size 2021-2034
  • Table 23: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 24: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034
  • Table 25: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 27: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 28: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size 2021-2034
  • Table 29: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 30: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034
  • Table 31: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 33: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 34: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size 2021-2034
  • Table 35: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 36: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Safety Pen Needles Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Safety Pen Needles Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Safety Pen Needles Market Value Share (%), by Drug Type, 2025 & 2034
  • Figure 4: Global Safety Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2034
  • Figure 5: Global Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 6: Global Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 7: Global Safety Pen Needles Market Value (USD million), by Region, 2025 & 2034
  • Figure 8: North America Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 9: North America Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 10: North America Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 11: North America Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 12: North America Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 13: North America Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 14: North America Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 15: North America Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 16: North America Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 17: North America Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 18: North America Safety Pen Needles Market Value (USD million), By Country, 2025 & 2034
  • Figure 19: North America Safety Pen Needles Market Value Share (%), By Country, 2025
  • Figure 20: Europe Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 21: Europe Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 22: Europe Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 23: Europe Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 24: Europe Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 25: Europe Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 26: Europe Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 27: Europe Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 28: Europe Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 29: Europe Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 30: Europe Safety Pen Needles Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 31: Europe Safety Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 32: Asia Pacific Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 33: Asia Pacific Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 34: Asia Pacific Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 35: Asia Pacific Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 36: Asia Pacific Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 37: Asia Pacific Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 38: Asia Pacific Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 39: Asia Pacific Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 40: Asia Pacific Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 41: Asia Pacific Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 42: Asia Pacific Safety Pen Needles Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Safety Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 44: Latin America Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 45: Latin America Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 46: Latin America Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 47: Latin America Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 48: Latin America Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 49: Latin America Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 50: Latin America Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 51: Latin America Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 52: Latin America Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 53: Latin America Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 54: Latin America Safety Pen Needles Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 55: Latin America Safety Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 56: Middle East & Africa Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 57: Middle East & Africa Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 58: Middle East & Africa Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 59: Middle East & Africa Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 60: Middle East & Africa Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 61: Middle East & Africa Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 62: Middle East & Africa Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 63: Middle East & Africa Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 64: Middle East & Africa Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 65: Middle East & Africa Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 66: Middle East & Africa Safety Pen Needles Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Safety Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 68: Global Pen Needles Market Share (%), 2025